The A's, B's, and ZZZ's of Sleep in RA and Lupus

Join the UNC School of Medicine Thurston Arthritis Research Center for a UNC Core Center for Clinical Research (CCCR) Speaker Series seminar featuring Patti Katz, PhD. Katz is a Professor of Medicine and Health Policy at the University of California San Francisco.

In this talk, Katz will review what we know about sleep in both conditions and how sleep may be related to disease outcomes. She will also talk about her research in the area of sleep in RA and lupus.

Join ZOOM Meeting

FDA Clinical Investigator Training Course

This course is designed to promote professionalism in the clinical trial industry for individuals involved with submissions to FDA (Investigational New Drug (IND) application, New Drug Application (NDA), Biologics License Application (BLA)), and to familiarize stakeholders with the regulatory and scientific issues involved in the development and approval of medical drugs and biological products.

INTENDED AUDIENCE: This is a clinical investigator training course targeted at all stakeholders in the clinical trial enterprise including industry, academia, and regulators (both local and foreign).

Register

NC BERD Seminar: Interaction and effect modification: what are they and how are they different

This advanced-level session will introduce, describe, and distinguish causal interaction and effect measure modification.

Presenter: Mike Bancks, PhD, MPH
Assistant Professor, Epidemiology and Prevention, Wake Forest University School of Medicine

This event is hosted by Wake Forest and being cross-promoted by the NC BERD Consortium, a collaboration of the CTSA-funded BERD cores at UNC-Chapel Hill, Wake Forest University School of Medicine, and Duke University School of Medicine.

FDA Clinical Investigator Training Course

This course is designed to promote professionalism in the clinical trial industry for individuals involved with submissions to FDA (Investigational New Drug (IND) application, New Drug Application (NDA), Biologics License Application (BLA)), and to familiarize stakeholders with the regulatory and scientific issues involved in the development and approval of medical drugs and biological products.

INTENDED AUDIENCE: This is a clinical investigator training course targeted at all stakeholders in the clinical trial enterprise including industry, academia, and regulators (both local and foreign).

Register

A Pragmatic Randomized Trial of the Jumpstart Intervention to Promote Communication About Goals of Care for Hospitalized Patients with Serious Illness

This NIH Collaboratory Rethinking Clinical Trials Grand Rounds features:

Ruth Engelberg, PhD
University of Washington

Erin Kross, MD
University of Washington

Robert Lee, MD, MS
University of Washington

Learn More